Susanne Catherine Hay, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neonatology | 2 | 2021 | 142 | 1.110 |
Why?
|
| Uncertainty | 2 | 2021 | 761 | 0.530 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 1366 | 0.400 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 10383 | 0.230 |
Why?
|
| Self Tolerance | 1 | 2011 | 119 | 0.180 |
Why?
|
| Th2 Cells | 1 | 2013 | 1075 | 0.140 |
Why?
|
| Hemiptera | 1 | 2006 | 7 | 0.140 |
Why?
|
| Animal Communication | 1 | 2006 | 18 | 0.140 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2006 | 70 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 1150 | 0.130 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 296 | 0.120 |
Why?
|
| Sound | 1 | 2006 | 257 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3228 | 0.100 |
Why?
|
| Heart Transplantation | 2 | 2013 | 3310 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2017 | 2914 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2011 | 4020 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2011 | 5501 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2013 | 4501 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 3110 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 5529 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7846 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2022 | 26337 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2013 | 6219 | 0.050 |
Why?
|
| Logistic Models | 1 | 2017 | 13266 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2013 | 249 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 478 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2013 | 23588 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 1746 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2011 | 962 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2013 | 14445 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2013 | 18970 | 0.030 |
Why?
|
| Head | 1 | 2022 | 925 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 2011 | 1098 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 27178 | 0.030 |
Why?
|
| Vibration | 1 | 2006 | 334 | 0.030 |
Why?
|
| Ligands | 1 | 2011 | 3273 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 36542 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22323 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2006 | 1206 | 0.020 |
Why?
|
| Graft Survival | 1 | 2011 | 3901 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 1999 | 0.020 |
Why?
|
| Humans | 3 | 2022 | 765823 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9241 | 0.020 |
Why?
|
| Mice | 2 | 2013 | 81788 | 0.020 |
Why?
|
| Animals | 3 | 2013 | 168730 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 5767 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4961 | 0.010 |
Why?
|
| Male | 1 | 2006 | 363740 | 0.000 |
Why?
|